Who Owns Ovid Therapeutics Stock?
NASDAQ: OVIDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 85.95%
- Held by insiders
- 7.33%
- Institutional holders
- 168
- Institutions 85.9%
- Insiders 7.3%
- Public and other 6.7%
Who owns Ovid Therapeutics stock?
Institutional investors own about 85.9% of Ovid Therapeutics's shares, spread across 168 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 7.33% of OVID.
The largest institutional holders are Jupiter Topco LLC (10.99%), Eventide Asset Management LLC (6.26%) and Blackrock Inc. (5.73%). Together, the top 10 institutions control 52.1% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their OVID positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of OVID
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Jupiter Topco LLC | 20.74M | 10.99% | +100.0% |
| Eventide Asset Management LLC | 11.81M | 6.26% | +19.1% |
| Blackrock Inc. | 10.82M | 5.73% | +605.9% |
| RA Capital Management, L.P. | 10.50M | 5.56% | -2.0% |
| Affinity Asset Advisors, Llc | 10.14M | 5.38% | -4.6% |
| Vanguard Capital Management LLC | 7.76M | 4.11% | +47.6% |
| Adar1 Capital Management, LLC | 7.42M | 3.93% | +63.2% |
| Balyasny Asset Management LP | 6.72M | 3.56% | +21.4% |
| State Street Corporation | 6.20M | 3.29% | -21.5% |
| Adage Capital Partners GP L.L.C. | 6.16M | 3.27% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of OVID
| Fund | Shares | % Held |
|---|---|---|
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund | 5.95M | 3.15% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 5.65M | 3.00% |
| iShares Trust-iShares Russell 2000 ETF | 4.23M | 2.24% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.78M | 1.47% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.95M | 1.03% |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 1.93M | 1.02% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.68M | 0.89% |
| iShares Trust-iShares Russell 2000 Value ETF | 1.35M | 0.72% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 876.76K | 0.46% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 835.31K | 0.44% |
Frequently asked questions
Who is the largest shareholder of Ovid Therapeutics?
Jupiter Topco LLC is the largest institutional shareholder of OVID, owning 10.99% of shares outstanding (20.74M shares) as of its latest 13F filing.
What percentage of Ovid Therapeutics is owned by institutions?
Institutions own about 85.9% of OVID shares and 92.7% of the public float.
How much of Ovid Therapeutics do insiders own?
Insiders, such as officers and directors, own about 7.33% of OVID shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.